214
Views
1
CrossRef citations to date
0
Altmetric
Review

Update on the efficacy, effectiveness and safety of artemether–lumefantrine combination therapy for treatment of uncomplicated malaria

, , , , &
Pages 11-20 | Published online: 16 Dec 2009

References

  • WHOhttp://wwwwhoint/mediacentre/factsheets/fs094/en/indexhtml Accessed July 2, 2009.
  • BremanJGAlilioMSMillsAConquering the intolerable burden of malaria: what’s new, what’s needed: a summaryAm J Trop Med Hyg200471211515331814
  • WHO/CDS/RBM/2000.17. The Abuja Declaration and the Plan of Action. 2000 April 25.
  • ChecchiFPiolaPFoggCSupervised versus unsupervised antimalarial treatment with six-dose artemether-lumefantrine: PK and dosage-related findings from a clinical trial in UgandaMalar J20061955916854236
  • MutabingwaTKAnthonyDHellerAAmodiaquine alone, amodiaquine + sulfadoxine-pyrimethamine, amodiaquine + artesunate, and artemether-lumefantrinefor outpatient treatment of malaria in Tanzanian children: a four arm randomised effectiveness trialLancet20053651474148015850631
  • AjayiIOBrowneENBateganyaFEffectiveness of artemisinin-based combination therapy used in the context of home management of malaria: a report from three study sites in sub-Saharan AfricaMalar J200827719018822170
  • WHOWorld Malaria ReportGenevaWorld Health Organization2008
  • OmariAAGambleCLGarnerPArtemether-lumefantrine (four-dose regimen) for treating uncomplicated falciparum malariaCochrane Database Syst Rev2006192CD00596516625646
  • OmariAAGambleCLGarnerPArtemether-lumefantrine (six-dose regimen) for treating uncomplicated falciparum malariaCochrane Database Syst Rev20054CD005564
  • TravassosMarkALauferResistance to antimalarial drugs: molecular, pharmacologic, and clinical considerationsPediatr Res200965564R70R
  • WhiteNJVan VugtMEzzetFEzzetFClinical Pharmacokinetics and pharmacodynamics of artemetherlumefantrineClin Pharmacokinet19993710512510496300
  • KokwaroGMwaiLNzilaAArtemether/lumefantrine in the treatment of uncomplicated falciparum malariaExpert Opin Pharmacother20078759417163809
  • GolenserJWaknineJHKrugliakMCurrent perspectives on the mechanisms of action of artemisininsInt J Parasitol2006361427144117005183
  • AweekaFTGermanPIClinical pharmacology of artemisinin-based combination therapiesClin Pharmacokinet20084729110218193915
  • AbdullaSBorrmannSD’AlessandroUEfficacy and safety of artemetherlumefantrine dispersible tablets compared with crushed commercial tablets in African infants and children with uncomplicated malaria: a randomised, single-blind, multicentre trialLancet20083721819182718926569
  • AbdullaSSagaraIDispersible formulation of artemether/lumefantrine: specifically developed for infants and young childrenMalar J2009811186/475-2875-8-S1–S7.
  • EzzetFMullRKarbwangJPopulation pharmacokinetics and therapeutic response of CGP 56697 (artemether + benflumetol) in malaria parasitesBr J Clin Pharmacol1998465535619862244
  • WhiteNPreventing antimalarial drug resistance through combinationsDrug Resistance Updates199813917092790
  • DjimdéALefèvreGUnderstanding the pharmacokinetics of Coartem®Malar J2009811186/475-2875-8-S1–S4.
  • EzzetFVan VugtMNostenFPharmacokinetics and pharmacodynamics of lumefantrine (benflumetol) in acute falciparum malariaAntimicrob Agents Chemother20004469770410681341
  • AshleyEAStepniewskaKLindegårdhNPharmacokinetic study of artemether–lumefantrine given once daily for the treatment of uncomplicated multidrugresistant falciparum malariaTrop Med Int Health20071220120817300626
  • PremjiZGAbdullaSOgutuBThe content of African diets is adequate to achieve optimal efficacy with fixed-dose artemether-lumefantrine: a review of the evidenceMalar J2008724419032767
  • Michael MakangaSKThe clinical efficacy of artemether/lumefantrine (Coartem®)Malar J2009811186/475-2875-8-S1–5.
  • Van VugtMWilairatanaPGemperliBEfficacy of six doses of artemether/lumefantrine (benflumetol) in multidrug-resistant Plasmodium falciparum malariaAm J Trop Med Hyg19996093694210403324
  • Van VugtMLooareesuwanSWilairatanaPArtemether/lumefantrine for the treatment of multi-drug resistant falciparum malariaTrans R Soc Trop Med Hyg20009454554811132386
  • LefèvreGLooareesuwanSTreeprasertsukSA clinical and PK trial of six doses of artemether-lumefantrine for multidrug-resistant Plasmodium falciparum malaria in ThailandAm J Trop Med Hyg20016456247256
  • HatzCSotoJNothdurftHDTreatment of acute uncomplicated falciparum malaria with artemether/lumefantrine in non-immune populations: a safety, efficacy and PK studyAm J Trop Med Hyg20087824124718256423
  • RojanawatsirivejCVijaykadgaSAmkladIMonitoring the therapeutic efficacy of antimalarials against uncomplicated falciparum malaria in ThailandSoutheast Asian J Trop Med Public Health20033453654115115123
  • BukirwaHYekaAKamyaMRArtemisinin Combination Therapies for Treatment of Uncomplicated Malaria in UgandaPLos Clin Trials2006110010007
  • DorseyGStaedkeSClarkTDCombination therapy for uncomplicated falciparum malaria in Ugandan childrenJAMA20072972210221917519410
  • GürkovREshetuTMirandaIBOtotoxicity of artemether/lumefantrine in the treatment of falciparum malaria: a randomized trialMalar J2008717918796142
  • KabanywanyiAMMwitaASumariDEfficacy and safety of artemisinin-based antimalarial in the treatment of uncomplicated malaria in children in southern TanzaniaMalar J2007614617996121
  • KamyaMRYekaABukirwaHArtemether/lumefantrine versus dihydroartemisinin-piperaquine for treatment of malaria: a randomized trialPLoS Clin Trials20072e2017525792
  • MårtenssonAStrömbergJSisowathCEfficacy of artesunate plus amodiaquine versus that of artemether/lumefantrine for the treatment of uncomplicated childhood Plasmodium falciparum malaria in Zanzibar, TanzaniaClin Infect Dis2005411079108716163624
  • MårtenssonANgasalaBUrsingJInfluence of consecutive-day blood sampling on polymerase chain reaction–adjusted parasitological cure rates in an antimalarial-drug trial conducted in TanzaniaJ Infect Dis200719559760117230421
  • MohamedAOEltaibEHAhmedOAThe efficacies of artesunate-sulfadoxine-pyrimethamine and artemether/lumefantrine in the treatment of uncomplicated, Plasmodium falciparum malaria, in an area of low transmission in central SudanAnn Trop Med Parasitol200610051016417707
  • MukhtarEAGadallaNBEl-zakiSEGA comparative study on the efficacy of artesunate plus sulphadoxine/pyrimethamine versus artemether/lumefantrine in eastern SudanMalar J200769217631681
  • YekaADorseyGKamyaMRArtemether/lumefantrine versus dihydroartemisinin-piperaquine for treating uncomplicated malaria: a randomized trial to guide policy in UgandaPLoS ONE20083e239018545692
  • MulengaMVan geertruydenJPMwananyandaLSafety and efficacy of lumefantrine-artemether (Coartem®) for the treatment of uncomplicated Plasmodium falciparum malaria in Zambian adultsMalar J200657316923176
  • TooveySEffectiveness of co-artemether in an unsupervised outpatient setting for the treatment of falciparum malariaTravel Med Infect Dis2008612293118342266
  • AdjeiGOKurtzhalsJARodriguesOPAmodiaquine artesunate vs artemether/lumefantrine for uncomplicated malaria in Ghanaian children: a randomized efficacy and safety trial with one year follow-upMalar J2008712718620577
  • FayeBNdiayeJLNdiayeDEfficacy and tolerability of four antimalarial combinations in the treatment of uncomplicated Plasmodium falciparum malaria in SenegalMalar J200768017570848
  • KoramKAAbuakuBDuahNComparative efficacy of anti-malarial drugs including ACTs in the treatment of uncomplicated malaria among children under 5 years in GhanaActa Trop20059519420316054584
  • MeremikwuMAlaribeAEjemotRArtemether/lumefantrine versus artesunate plus amodiaquine for treating uncomplicated childhood malaria in Nigeria: randomized controlled trialMalar J200654316704735
  • Owusu-AgyeiSAsanteKPOwusuRAn open label, randomised trial of artesunate + amodiaquine, artesunate + chlorproguanil-dapsone and artemether/lumefantrine for the treatment of uncomplicated malariaPLoS ONE20083e253018575626
  • SagaraIDickoADjimdeAA randomized trial of artesunate-sulfamethoxypyrazinepyrimethamine versus artemether/lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria in MaliAm J Trop Med Hyg20067563063617038684
  • SowunmiAGbotoshoGOHappiCTTherapeutic efficacy and effects of artemether/lumefantrine and amodiaquine-sulfalenepyrimethamine on gametocyte carriage in children with uncomplicated Plasmodium falciparum malaria in southwestern NigeriaAm J Trop Med Hyg20077723524117690392
  • SutherlandCJOrdRDunyoSReduction of malaria transmission to Anopheles mosquitoes with a sixdose regimen of co-artemetherPLoS Med20052e9215839740
  • ZongoIDorseyGRouambaNArtemether/lumefantrine versus amodiaquine plus sulfadoxine-pyrimethamine for uncomplicated falciparum malaria in Burkina Faso: a randomized non-inferiority trialLancet200736949149817292769
  • ZongoIDorseyGRouambaNRandomized comparison of amodiaquine plus sulfadoxine-pyrimethamine, artemether/lumefantrine, and dihydroartemisinin-piperaquine for the treatment of uncomplicatedPlasmodium falciparum malaria in Burkina FasoClin Infect Dis2007451453146117990228
  • FanelloCIKaremaCvan DorenWA randomised trial to assess the safety and efficacy of artemether/lumefantrine (Coartem®) for the treatment of uncomplicated Plasmodium falciparum malaria in RwandaTrans R Soc Trop Med Hyg200710134435017005222
  • GuthmannJPCohuetSRiguttoCHigh efficacy of two artemisinin-based combinations (artesunate + amodiaquine and artemether + lumefantrine) in Caala, Central AngolaAm J Trop Med Hyg20067514314516837721
  • NdayiragijeANiyungekoDKarenzoJEfficacité de combinaisons thérapeutiques avec des dérivés de l’artémisinine dans le traitement de l’accès palustre noncomplique au BurundiTrop Med Int Health2004967367915189457
  • Van den BroekIKitzCAl AttasSEfficacy of three artemisinin combination therapies for the treatment of uncomplicated Plasmodium falciparum malaria in the Republic of CongoMalar J2006511317125496
  • KrudsoodSChalermrutKPengruksaCComparative clinical trial of two-fixed combinations dihydroartemisinin-napthoquine-trimethoprim (DNP®) and artemether/lumefantrine Coartem®/Riamet®) in the treatment of acute uncomplicated falciparum malaria in ThailandSoutheast Asian J Trop Med Public Health20033431632112971556
  • StohrerJMDittrichSThongpaseuthVTherapeutic efficacy of artemether/lumefantrine and artesunate-mefloquine for treatment of uncomplicated Plasmodium falciparum malaria in Luang Namtha Province, Lao People’s Democratic RepublicTrop Med Int Health200491175118315548313
  • MayxayMKhanthavongMLindegårdhNRandomized comparison of chloroquine plus sulfadoxine-pyrimethamine versus artesunate plus mefloquine versus artemether/lumefantrine in the treatment of uncomplicated falciparum malaria in the Lao People’s Democratic RepublicClin Infect Dis2004391139114715486837
  • RatcliffASiswantoroHKenangalemETwo fixed-dose artemisinin combinations for drug-resistant falciparum and vivax malaria in Papua, Indonesia: an open-label randomised comparisonLancet200736975776517336652
  • HutagalungRPaiphunLAshleyEAA randomized trial of artemether/lumefantrine versus mefloquine-artesunate for the treatment of uncomplicated multi-drug resistant Plasmodium falciparum on the western border of ThailandMalar J200544616179089
  • Van den BroekIVMaungUAPetersAEfficacy of chloroquine + sulfadoxine-pyrimethamine, mefloquine + artesunate and artemether + lumefantrine combination therapies to treat Plasmodium falciparum malaria in the Chittagong Hill Tracts, BangladeshTrans R Soc Trop Med Hyg20059972773516095643
  • HaqueRThriemerKWangZTherapeutic efficacy of artemether/lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria in BangladeshAm J Trop Med Hyg200776394117255226
  • ThapaSHollanderJLinehanMComparison of artemether/lumefantrine with sulfadoxine-pyrimethamine for the treatment of uncomplicated falciparum malaria in Eastern NepalAm J Trop Med Hyg20077742343017827354
  • JansenFHLesaffreEPenaliLKAssessment of the relative advantage of various artesunate-based combination therapies by a multi-treatment Bayesian random-effects meta-analysisAm J Trop Med Hyg2007771005100918165512
  • PiolaPFoggCBajunirweFSupervised versus unsupervised intake of six-dose artemether-lumefantrine for treatment of acute, uncomplicated Plasmodium falciparum malaria in Mbarara, Uganda: a randomised trialLancet200536594691467147315850630
  • AchanJTibenderanaJKyabayinzeDEffectiveness of quinine versus artemether-lumefantrine for treating uncomplicated falciparum malaria in Ugandan children: randomised trialBMJ200933927632763
  • FaladeCMakangaMPremjiZEfficacy and safety of artemether/lumefantrine (Coartem®) tablets (six-dose regimen) in African infants and children with acute, uncomplicated falciparum malariaTrans R Soc Trop Med Hyg20059945946715837358
  • FaladeCManyandoCSafety profile of Coartem®: the evidence baseMalar J20098Suppl 1S619818173
  • TooveySJamiesonAAudiometric changes associated with the treatment of uncomplicated falciparum malaria with coartemetherTrans R Soc Trop Med Hyg20049826126715109547
  • MillerLGPanosianCBAtaxia and slurred speech after artesunate treatment for falciparum malariaN Engl J Med199733613289132599
  • CousinMKummererSLefèvreGAdvisory Committee Briefing Book. Coartem® (artemether/lumefantrine) tablets for the treatment of malaria in patients with acute, uncomplicated infections due to Plasmodium falciparum or mixed infections includingP falciparumhttp://wwwfdagov/ohrms/dockets/ac/08/briefing/2008-4388b1-02-Novartispdf 2008
  • BakshiRHermeling-FritzIGathmannIAn integrated assessment of the clinical safety of artemether-lumefantrine:a new oral fixed-dose combination antimalarial drugTrans R Soc Trop Med Hyg20009441942411127248
  • Nankabirwa ZurovacDNjoguJNMalaria misdiagnosis in Uganda—implications for policy changeMalar J200916866
  • TalisunaAOStaedkeSGD’AlessandroUPharmacovigilance of antimalarial treatment in Africa: is it possible?Malar J200655016780575
  • BarnesKILittleFSmithPJSulfadoxine-pyrimethamine PKs in malaria: pediatric dosing implicationsClin Pharmacol Ther20068058259617178260
  • PriceRNHasugianARRatcliffAClinical and pharmacological determinants of the therapeutic response to dihydroartemisinin-piperaquine for drug-resistant malariaAntimicrob Agents Chemother2007514090409717846129
  • ter KuileFOTerlouwDJKariukiSKImpact of permethrin-treated bed nets on malaria, anemia, and growth in infants in an area of intense perennial malaria transmission in western KenyaAm J Trop Med Hyg200368687712749488
  • SlutskerLTaylorTEWirimaJJIn-hospital morbidity and mortality due to malaria-associated severe anaemia in two areas of Malawi with different patterns of malaria infectionTrans R Soc Trop Med Hyg1994885485517992335
  • SchellenbergDMenendezCKahigwaEAfrican children with malaria in an area of intense Plasmodium falciparum transmission: features on admission to the hospital and risk factors for deathAm J Trop Med Hyg19996143143810497986
  • NostenFWhiteNJArtemisinin-based combination treatment of Falciparum malariaAm J Trop Med Hyg200777618119218165491
  • LongoMZanoncelliSManeraDEffects of the antimalarial drug dihydroartemisinin (DHA) on rat embryos in vitroReprod Toxicol2006211839316026965
  • DellicourSO ter KuileFStergachisAPregnancy exposure registries for assessing antimalarial drug safety in pregnancy in malaria-endemic countriesPLoS Med200859187
  • NostenFMcGreadyRMutabingwaTCase management of malaria in pregnancyLancet Infect Dis20077211812517251082
  • McGreadyRChoTKeoNKArtemisinin antimalarials in pregnancy: a prospective treatment study of 539 episodes of multidrug-resistant Plasmodium falciparumClin Infect Dis200133122009201611712093
  • DellicourSHallSChandramohanDThe safety of artemisinins during pregnancy: a pressing questionMalar J20071461517300719
  • AdamIElhassanEMOmerEMAbdullaMASafety of artemisinins during early pregnancy, assessed in 62 Sudanese womenAnn Trop Med Parasitol2009103320521019341535
  • ManyandoCMkandawireRPumaLSafety profile artemether-lumefantrine (AL; Coartem®) compared sulfadoxine-pyrimethamine (SP) pregnant women symptomatic malaria: preliminary results of an observational studyAbstract 570, 57th Meeting of the American Society of Tropical Medicine and Hygiene (ASTMH)New Orleans, Louisiana, USADecember 2008
  • TarningJMcGreadyRLindegardhNPopulation PKs of lumefantrine in pregnant women treated with artemether-lumefantrine for uncomplicated P. falciparum malariaAntimicrob Agents Chemother2009533837384619564366
  • McGreadyRStepniewskaKLindegardhNThe pharmacokinetics of artemether and lumefantrine in pregnant women with uncomplicated falciparum malariaEur J Clin Pharmacol200662121021103117053895
  • McGreadyRTanSOAshleyEAA randomised controlled trial of artemether-lumefantrine versus artesunate for uncomplicated Plasmodium falciparum treatment in pregnancyPLoS Med2008235e25319265453
  • WhitworthJMorganDQuigleyMEffect of HIV-1 and increasing immunosuppression on malaria parasitaemia and clinical episodes in adults in rural Uganda: a cohort studyLancet200035692351051105611009139
  • FrenchNNakiyingiJLugadaEIncreasing rates of malarial fever with deteriorating immune status in HIV-1-infected Ugandan adultsAIDS200115789990611399962
  • FrancesconiPFabianiMDenteMGHIV, malaria parasites, and acute febrile episodes in Ugandan adults: a case-control studyAIDS200115182445245011740196
  • AtzoriCBrunoAChichinoGHIV-1 and parasitic infections in rural TanzaniaAnn Trop Med Parasitol19938765855938122920
  • Van EijkAMAyisiJGTer KuileFOHIV increases the risk of malaria in women of all gravidities in Kisumu, KenyaAIDS200317459560312598780
  • VerhoeffFHBrabinBJHartCAIncreased prevalence of malaria in HIV-infected pregnant women and its implications for malaria controlTrop Med Int Health19994151210203167
  • SteketeeRWWirimaJJSlutskerLComparability of treatment groups and risk factors for parasitemia at the first antenatal clinic visit in a study of malaria treatment and prevention in pregnancy in rural MalawiAm J Trop Med Hyg199655117238702032
  • ShulmanImportance and prevention of malaria in pregnancyTrans R Soc Trop Med Hyg2003971303512886801
  • BlolandPBWirimaJJSRChilimaBMaternal HIV infection and infant mortality in Malawi: evidence for increased mortality due to placental malaria infectionAIDS1995977217267546417
  • Byakika-KibwikaPDdumbaEKamyaMEffect of HIV-1 infection on malaria treatment outcome in Ugandan patientsAfrican Health Sciences200772869217594285
  • KamyaMRKigonyaCNMcFarlandWHIV infection may adversely affect clinical response to chloroquine therapy for uncomplicated malaria in childrenAIDS20011591187118811416726
  • KamyaMRGasasiraAFYekaAEffect of HIV-1 infection on antimalarial treatment outcomes in Uganda: a population-based studyJ Infect Dis2006193191516323126
  • ColebundersRBahweYNekweiWIncidence of malaria and efficacy of oral quinine in patients recently infected with human immunodeficiency virus in Kinshasa, ZaireJ Infect Dis1990212167173
  • Van GeertruydenJPMulengaMMwananyandaLHIV-1 immune suppression and antimalarial treatment outcome in Zambian adults with uncomplicated malariaJ Infect Dis2006194791792516960779
  • BirkuYMEBjörkmanAWoldayDDelayed clearance of Plasmodium falciparum in patients with human immunodeficiency virus co-infection treated with artemisininEthiop Med J20021172612802828
  • PatnaikPJereCSMillerWCEffects of HIV-1 serostatus, HIV-1RNA concentration, and CD4 cell count on the incidence of malaria infection in a cohort of adults in rural MalawiJ Infect Dis200519298499116107950
  • Van GeertruydenJPMulengaMKasongoWCD4 T-cell count and HIV-1 infection in adults with uncomplicated malariaJ Acquir Immune Defic Syndr200643336336717079994
  • KhooSBackDWinstanleyPThe potential for interactions between antimalarial and antiretroviral drugsAIDS20051910995100515958830
  • KamyaMoses RYekaAdokeBukirwaHasfaArtemether-lumefantrine versus dihydroartemisinin-piperaquine for treatment of malaria: a randomized trialPLoS Clin Trials2007251371
  • GasasiraAFKamyaMRAchanJHigh risk of neutropenia in HIV-infected children follwoing treatment with artesunate for uncomplicated malaria in UgandaCID200846985991
  • GermanPParikhSLawrenceJLopinavir/ritonavir affects PK exposure of artemether/lumefantrine in HIV-uninfected healthy volunteersJ Acquir Immune Defic Syndr200951442442919506482
  • SousaMPozniakABoffitoMPharmacokinetics and pharmacodynamics of drug interactions involving rifampicin, rifabutin and antimalarial drugsJ Antimicrob Chemother200862587287818713760
  • LefevreGPK and electrocardiographic pharmacodynamics of artemether-lumefantrine (Riamet®) with concomitant administration of ketoconazole in healthy subjectsBr J Clin Pharmacol20025448549212445027
  • BlolandPBDrug resistance in malariaWHO/CDS/CSR/DRS/20014. 2001
  • HuongNMHweittSDavisTMResistance of P. falciparum to anti-malarial drugs in a highly endemic area in southern Viet Nam: a study in vivo and vitroTrans R Soc Trop Med Hyg20019532532911491008
  • YangHLiuDYangYChanges in susceptibility of Plasmodium falciparum to artesunate in vitro in Yunnan Province, ChinaTrans R Soc Trop Med Hyg20039722622814584382
  • GordonPKellyRHedderwickSFailure of artemether-lumefantrine (Riamet) to clear Plasmodium falciparum in non immune travellerAbstract. First Interanational Conference of Travel Medicine and Infectious DiseaseLondon, UK2005
  • YangsutakaMizunoYasuyukiKatoKoichiroKudoFirst case of Treatment failure of artemether-lumefantrine in a Japanese traveler with imported falciparum malariaJpn J Infect Dis20096213914119305055
  • SisowathCStrombergJMartenssonAIn vivo selection of Plasmodium falciparum pfmdr1 86N coding alleles by artemether-lumefantrine (Coartem)J Infect Dis20051911014101715717281
  • DuraisinghMTJonesPSambouIvon SeidleinLPinderMWarhurstDCThe tyrosine-86 allele of the pfmdr1 gene of Plasmodium falciparum is associated with increased sensitivity to the anti-malarials mefloquine and artemisininMol Biochem Parasitol2000108132310802315
  • NewtonPNFernandezFMPlanconAA collaborative epidemiological investigation into the criminal fake artesunate trade in South East AsiaPLoS Med20085e3218271620
  • AtemnkengMADe CockKPlaizier-VercammenJQuality control of active ingredients in artemisinin-derivative antimalarials within Kenya and DR CongoTrop Med Int Health200712687417207150
  • BateRCoticelliPTrenRAntimalarial drug quality in the most severely malarious parts of Africa-a six country studyPLoS ONE20083e213218461128